Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID‐19-Reference-Cited by-同舟云学术

Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID‐19

Published:2020-08-28 Issue:6 Volume:45 Page:1515-1519
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Sahebnasagh Adeleh¹,Saghafi Fatemeh²,Safdari Mohammadreza³,Khataminia Masoud⁴,Sadremomtaz Afsaneh⁵,Talaei Zeinab⁶,Rezai Ghaleno Hassan⁷,Bagheri Mahdi⁸,Habtemariam Solomon⁹,Avan Razieh¹⁰^ORCID

Affiliation:

1. Department of Internal Medicine Clinical Research Center Faculty of Medicine North Khorasan University of Medical Sciences Bojnurd Iran

2. Department of Clinical Pharmacy Faculty of Pharmacy and Pharmaceutical Sciences Research Center Shahid Sadoughi University of Medical Sciences Yazd Iran

3. Department of Orthopedic Surgery Faculty of Medicine North Khorasan University of Medical Sciences Bojnurd Iran

4. Student Research Committee Faculty of Pharmacy Tehran University of Medical Sciences Tehran Iran

5. XB20 Drug Design Groningen Research Institute of Pharmacy University of Groningen Groningen The Netherlands

6. Department of Chemistry Faculty of Science Shahid Rajaee Teacher Training University Tehran Iran

7. Department of Surgery Faculty of Medicine Lorestan University of Medical Sciences Khorramabad Iran

8. Baqiyatallah Hospital Baqiyatallah University of Medical Sciences Tehran Iran

9. Pharmacognosy Research Laboratories and Herbal Analysis Services School of Science University of Greenwich Kent UK

10. Department of Clinical Pharmacy, Medical Toxicology and Drug Abuse Research Center (MTDRC) Faculty of Pharmacy Birjand University of Medical Sciences Birjand Iran

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13251

Reference50 articles.

1. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

2. Pathological findings of COVID-19 associated with acute respiratory distress syndrome

3. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

4. COVID-19: Melatonin as a potential adjuvant treatment

5. Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blocking HXA ₃ -mediated neutrophil elastase release during S. pneumoniae lung infection limits pulmonary epithelial barrier disruption and bacteremia;mBio;2024-09-11

2. Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of ALI/ARDS patients with COVID-19;Heliyon;2024-09

3. Human Neutrophil Elastase: Characterization of Intra- vs. Extracellular Inhibition;International Journal of Molecular Sciences;2024-07-19

4. Psychological Status and Warfarin Therapy in Patients after Valve Replacement during the COVID-19 Pandemic: A Cross-sectional Study;Current Medical Science;2024-07-06

5. Recent Developments in the Role of Protein Tyrosine Phosphatase 1B (PTP1B) as a Regulator of Immune Cell Signalling in Health and Disease;International Journal of Molecular Sciences;2024-06-29